Literature DB >> 4063915

Estrogen receptor status of breast cancer in Ontario.

G E McKeown-Eyssen, I Rogers-Melamed, E A Clarke.   

Abstract

Data from a number of studies of breast cancer have suggested that after the ages associated with the menopause the rates of estrogen-receptor-positive tumours increase with age, whereas the rates of estrogen-receptor-negative tumours do not. Previous investigators studied cases in specific treatment centres, so there was a possibility that the findings were influenced by differences in patterns of case referral by age. A review of all the cases of breast cancer diagnosed in Ontario women in 1981 and assayed for estrogen receptors, however, confirmed the earlier findings. The results showed that the incidence of estrogen-receptor-positive and estrogen-receptor-negative tumours increased at about the same rate before age 45, but thereafter an increase in incidence was seen only for estrogen-receptor-positive tumours. These differences in patterns of incidence suggest the possibility that the two types of tumour may have different etiologic factors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4063915      PMCID: PMC1346411     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  25 in total

1.  Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels.

Authors:  R Nagai; M Kataoka; S Kobayashi; K Ishihara; N Tobioka; K Nakashima; M Naruse; K Saito; S Sakuma
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

2.  Oestrogen receptors and peripheral serum levels of oestradiol-17beta in patients with mammary carcinoma.

Authors:  N O Theve; K Carlström; J A Gustafsson; S Gustafsson; B Nordenskjöld; H Sköldefors; O Wrange
Journal:  Eur J Cancer       Date:  1978-12       Impact factor: 9.162

3.  Hormone receptors: their role in predicting prognosis and response to endocrine therapy.

Authors:  W L McGuire
Journal:  Semin Oncol       Date:  1978-12       Impact factor: 4.929

4.  Association between steroid hormone receptor status and disease-free interval in breast cancer.

Authors:  J C Allegra; M E Lippman; R Simon; E B Thompson; A Barlock; L Green; K K Huff; H M Do; S C Aitken; R Warren
Journal:  Cancer Treat Rep       Date:  1979-08

5.  Estrone and estradiol content in human breast tumors: relationship to estradiol receptors.

Authors:  J Fishman; J S Nisselbaum; C J Menendez-Botet; M K Schwartz
Journal:  J Steroid Biochem       Date:  1977-08       Impact factor: 4.292

6.  Existence of receptors bound to endogenous estradiol in breast cancers of premenopausal and postmenopausal women.

Authors:  F Sakai; S Saez
Journal:  Steroids       Date:  1976-01       Impact factor: 2.668

7.  Prognostic value of estrogen receptor determinations in patients with breast cancer.

Authors:  M A Rich; P Furmanski; S C Brooks
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

8.  Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols.

Authors:  E D Ryan; A F Clark; B G Mobbs; T C Ooi; D J Sutherland; E R Tustanoff
Journal:  Clin Biochem       Date:  1985-02       Impact factor: 3.281

9.  Oestrogen receptors and prognosis in early breast cancer.

Authors:  T Cooke; D George; R Shields; P Maynard; K Griffiths
Journal:  Lancet       Date:  1979-05-12       Impact factor: 79.321

10.  Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.

Authors:  S Saez; P M Martin; C D Chouvet
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

View more
  2 in total

1.  Breast cancer incidence in young women by estrogen receptor status and race.

Authors:  J L Stanford; R S Greenberg
Journal:  Am J Public Health       Date:  1989-01       Impact factor: 9.308

2.  Influence of estrogen receptor status on dietary risk factors for breast cancer.

Authors:  T G Hislop; L Kan; A J Coldman; P R Band; G Brauer
Journal:  CMAJ       Date:  1988-03-01       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.